"#RickDoblin at #ICPR2024 on the current #MDMA therapy controversy".0 “We are still optimist about the 11th of August decision, even if there are additional requirements from the FDA. I worked on it for 38 years, even if it extends to 39 or 45 years, it doesn’t matter”.
https://x.com/tommaso_barba/status/1799110518067921345?s=46&t=oyGVJhOO7c3tLwP_j7fQmQ
Tommaso Barba (@tommaso_barba) on X
1/ Rick Doblin at #ICPR2024 on the current #MDMA therapy controversy “We are still optimist about the 11th of August decision, even if there are additional requirements from the FDA. I worked on it for 38 years, even if it extends to 39 or 45 years, it doesn’t matter”.
